Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A Randomized, Double-Blind, Placebo-Controlled Trial of Sertraline for Major Depression with Congestive Heart Failure

BACKGROUND: Sertraline, a selective serotonin-reuptake inhibitor (SSRI), has demonstrated substantial mood improvement in patients with post myocardial infarction or with unstable angina. The impact of sertraline on the prognosis and depression of patients with chronic heart failure (HF) and co-morb...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jiang, Wei, O’Connor, Christopher, Silva, Susan G., Kuchibhatla, Maragatha, Cuffe, Michael S., Callwood, Dwayne D., Zakhary, Bosh, Henke, Elizabeth, Arias, Rebekka M, Krishnan, Ranga
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2659472/
https://ncbi.nlm.nih.gov/pubmed/18760123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2008.05.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars